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Abstract
Objective : to determine risk factors in hydatidiform mole 
patients who will develop into Gestational Trophoblast 
Neoplasm (GTN) in Dr. Mohammad Hoesin Hospital 
Palembang
Methods : An observational analytical study with case-control 
design was conducted in the Department of Obstetrics and 
Gynecology in Dr. Mohammad Hoesin Hospital Palembang 
/ Faculty of Medicine Sriwijaya Universitas Palembang from 
January 2017 to August 2017. The frequency and distribution 
of data are described in tables. Bivariate analysis was done 
to determine the correlation between the independent 
variable and dependent variable using Chi-Square/Fisher 
Exact test and multivariate analysis was used to know which 
independent variable has the most signifi cant infl uence to 
the occurrence of Gestational Trophoblast Neoplasm (GTN) 
post-evacuation of hydatidiform mole. Data analysis was 
done using SPSS version 21.0. 
Results : 45 patients fulfi lled inclusion criteria with a 
control group and case group ratio 1 : 2 (15 cases and 30 
controls). Statistical analysis showed a signifi cant correlation 
between patient age, preevacuation β HCG level, parity, 
and histopathologic appearance with the occurrence of 
Gestational Trophoblast Neoplasm (GTN) after the evacuation 
of hydatidiform mole (p <0,05). From multivariate analysis, 
it was found that pre-evacuation β HCG levels ≥ 134,182.5 
mIU/ml were a risk factor of Gestational Trophoblast 
Neoplasm (OR = 77.008, p-value = 0.004).
Conclusions : Preevacuation β HCG levels ≥ 134,182.5 
mIU / ml isa risk factor for the occurrence of Gestational 
Trophoblast Neoplasm (GTN).
Keywords : age, blood type, hydatidiform mole, 
histopathology feature, GTN, preevacuation β HCG level, 
parity, uterine size.
Abstrak
Tujuan : Untuk mengetahui faktor-faktor risiko pada 
pasien–pasien molahidatidosa yang akan berkembang 
menjadi Tumor Trofoblas Gestasional (TTG) di Rumah Sakit 
Dr. Mohammad Hoesin Palembang
Metode : Penelitian analitik observasional dengan studi 
case control ini dilakukan di Departemen Obstetrik dan 
Ginekologi RSUP Dr. Mohammad Hoesin Palembang/ 
Fakultas Kedokteran Universitas Sriwijaya Palembang 
sejak bulan Januari 2017 sampai Agustus 2017. Frekuensi 
dan distribusi data dijelaskan dalam bentuk tabel, analisis 
bivariat untuk mengetahui ada tidaknya hubungan secara 
statistik antara variabel bebas dengan variabel terikat 
menggunakan ujiChi Square/ Fisher Exact  dan analisis 
multivariate untuk mengetahui variabel independen mana 
yang paling besar pengaruhnya terhadap kejadian Tumor 
Trofoblas Gestasional (TTG) pascaevakuasi molahidatidosa. 
Analisis data menggunakan SPSS versi 21.0.
Hasil : Didapatkan sampel sebanyak 45 pasien yang 
memenuhi kriteria inklusi. Dengan perbandingan kasus 
banding kontrol yaitu 1:2; sehingga didapatkan 15 pasien 
sebagai kasus dan 30 pasien sebagai kontrol. Dengan analisis 
statistika didapatkan hasil terdapat hubungan yang signifi kan 
antara usia pasien, kadar β HCG praevakuasi, paritas dangan 
gambaran histopatologi dengan kejadian Tumor Trofoblas 
Gestasional (TTG) pascaevakuasi molahidatidosa (p< 0,05). 
Denganan alisis multivariate didapatkan kadar β HCG 
praevakuasi dengan nilai ≥ 134.182,5 mIU/ml merupakan 
faktor risiko Tumor Trofoblas Gestasional (OR = 77,008, p 
value = 0,004 ).
Kesimpulan : Kadar β HCG praevakuasi dengan nilai ≥ 
134.182,5 mIU/ml merupakan faktor risiko kejadian Tumor 
Trofoblas Gestasional (TTG).
Kata kunci : gambaran histopatologi, golongan darah, 
kadar β HCG praevakuasi, molahidatidosa, paritas, TTG, 
ukuran uterus,  usia.
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INTRODUCTION
Hydatidiform mole is the most common form 
of gestational trophoblastic disease (GTD). 
Hydatidiform mole is an abnormal pregnancy 
in which some or all chorionicvillus degenerate 
into grape-like vesicles.1 Hydatidiform moles 
may be malignant or benign. The frequency of 
hydatidiform mole is generally higher in Asian 
women (1 in every 120 pregnancies) than in 
Western women (1 in every 2,000 pregnancies).2 
In Indonesia, hydatidiform moles are considered 
an important disease with high incidence (data at 
in hospitals in Indonesia, 1 per 40), multiple risk 
factors, uniform distribution and most of the data 
is still hospital-based.3
Several theories have been proposed to 
explain the pathogenesis of hydatidiform mole. 
According to a theory by Hertig and Mansell, the 
cause of hydatidiform mole is an inadequacy of 
fetal blood circulation. Trophoblast cells receive 
nutrition from the mother through the intervillous 
chamber then send the liquid to the villi. Due 
to the dysfunctional villous blood circulation, 
fl uid accumulates in villous mesenchymal tissue 
and forms small cysts. This continues and will 
eventually result in hydatidiform mole.4,5
Patient  with  normal pregnancy who  has 
previous  history of   hydatidiform mole is 
considered healthy, and hence, follow-up 
supervision is no longer necessary. If malignancy 
occurs, it is not caused by the former hydatidiform 
mole, but as a result of the last labour. A theory 
states a number of trophoblast cells in hydatidiform 
mole sometimes appear quiet (dormant cells) for 
some time and the existence of pregnancy (the 
infl uence of estrogen) reactivates these cells. In 
this case, the choriocarcinoma arises not from 
the last pregnancy, but the previous mole.4,5
Malignancy following evacuation of 
hydatidiform mole occurs in 15-20%. Post-
mole malignancy develops very rapidly with a 
high mortality number of 31-51 %.6,7 The risk of 
malignancy after the evacuation of the mole is 
not clearly known. Several demographic, clinical 
and laboratory variables have been studied as 
malignant risk factors such as age, parity, uterine 
size, lutein cyst, histopathological features 
and also pre-evacuation β-human chorionic 
gonadotropin (β-HCG) level.8-10
This study aimed to determine risk factors 
of the occurrence of Gestational Trophoblast 
Neoplasm (GTN) following hydatidiform mole 
evacuation, so it can be used to predict whether 
hydatidiform mole will develop into GTN 
(Gestational Trophoblastic Neoplasm) or return 
to normal.
METHOD
 This observational analytic study with case-control 
(retrospective) design was conducted in the 
Department of Obstetrics and Gynecology in Dr. 
Mohammad Hoesin hospital Palembang/ Faculty 
of Medicine Universitas Sriwijaya Palembang 
from January to August 2017. Data was collected 
by gathering medical record data of hydatidiform 
mole patients who came and were treated in the 
Department of Obstetrics and Gynecology in Dr. 
Mohammad Hoesin hospital Palembang from 
January 1st 2014 to December 31st 2016. Samples 
were selected using purposive sampling by 
choosing patient who met the research criteria. 
The sample was then divided into 2 groups, with 
1:2 proportion between the case group and 
the control group. The control group was the 
hydatidiform mole group that had regressed, and 
the case group was the hydatidiform mole group 
that developed into GTN. Independent variables 
were age, pre-evacuated HCG levels, blood type, 
parity, uterine size, histopathologic features.
Univariate analysis was performed on sample 
demographic characteristics. Bivariate analyses 
using chi-square or Fisher exact test were 
performed to assess the association between 
age, pre-evacuation HCG levels, blood type, 
parity, uterine size, histopathologic features and 
malignancy occurrences in hydatidiform mole. 
Logistic regression analysis was performed to 
determine which independent variables had the 
greatest effect on the occurrence of GTN after 
hydatidiform mole evacuation.
RESULT
There were 45 hydatidiform mole patients who 
met the inclusion criteria. Of the 45 patients 
with hydatidiform mole, 15 patients developed 
Gestational Trophoblast Neoplasm, and 30 
patients regressed.Of 45 patients,30 regressed 
patients(66,7%) have mean age 27,37 ± 7,63 
(age range 17-45 years old) and 15 patients 
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who developed into GTN(33.3%) have mean age 
35.13 ± 10.01 (age range 17-50 years old). Based 
on statistical analysis, there was a signifi cant 
difference in age between regressed patients and 
GTN patients (p = 0.006). 
The mean of pre-evacuation β HCG level in the 
regressed group was 69617,6 ± 38449,7 mIU/ml 
and the mean of pre-evacuation β HCG level in 
the GTN group was 515286,4 ± 346728,0 mIU/ml. 
From statistical analysis, it was found that there 
was a signifi cant difference in pre-evacuation 
HCG levels between the two groups (p = 0,000). 
No signifi cant difference was observed in both 
groups for other demographic and clinical 
characteristics (p> 0.05) as shown in Table 1.
ROC curve analysis was performed to obtain the 
cut-off point with the best sensitivity and specifi city 
values for age, parity and preevacuation β HCG 
level. Based on the ROC curve, the cut-off point 
was 29.5 years for age, the best parity at 1.5 and 
the best preevacuation β HCG level at 134.182,5 
mIU / ml. Analysis results from ROC curve for 
age, parity and β HCG is used to analyse the 
relationship between the independent variables 
and the occurrence of Gestational Trophoblast 
Neoplasm (GTN) in hydatidiform mole patients.
In GTN patients the majority (73.3%) of 
patients was ≥ 29.5 years old whereas in non-GTN 
patients the majority (66.7% )was<29.5 years old. 
For parity variables, in GTN patients the majority 
of patients had a parity of ≥ 1.5 (66.6%) whereas 
the majority non-GTN patients (73.3%) had parity 
<1.5. Meanwhile, for the predominant β HCG 
levels, the majority of patients (93.3%) of the GTN 
had pre-evacuation β HCG ≥ 134.182.5 mIU / ml, 
whereas the majority non-GTN patients (93.3%) 
of had pre-treatment β HCG levels <134.182.5 
mIU / ml. Table 2 shows that there is a signifi cant 
association between age, parity, pre-evacuation 
βHCG levels and histopathology features and 
gestational trophoblast neoplasm occurrence in 
hydatidiform mole patients (p <0.05).
Table 1. Characteristics of Subjects
Characteristics
Hydatidiform Mole
P-value
GTN Non-GTN
Age (years), mean ± SD
Pre-evacuation β HCG Levels, mean ± SD
35.13 ± 10.01
515286.4 ± 346728.0 69617.6 ± 38449.7 0.000***
27.37 ± 7.63 0.006*
Education, (n,%)
Elementary
Junior High School
Senior High School
College
Occupation, (n,%)
Housewife
Farmer
University student
Employee
Civil servant
Blood Group
A
B
O
AB
Uterine size
Bigger
Smaller/appropiate
*Independent T Test, p = 0,05 , **Pearson Chi Square, p = 0,05, ***Mann Whitney test, p = 0,05
*****Fisher Exact test, p=0,05
15(100)
0 (0)
29 (96.7)
1 (3.3)
1.000****
11 (73.3)
0 (0)
0 (0)
2 (13.3)
2 (13.3)
6 (40)
7 (46.7)
2 (13.3)
0 (0)
25 (83.3)
3 (10)
1 (3.3)
1 (3.3)
0 (0)
10 (33.3)
11 (36.7)
9 (30)
0 (0)
0.106**
0.470**
0 (0)
3 (20)
10 (66,7)
2 (13.3)
2 (6,7)
3 (10)
23 (76.7)
2 (6.7)
0.496**
Based on the logistic regression test in table 3, 
it was found that pre-evacuation β HCG level 
signifi cantly infl uenced the occurrence of GTN. 
Risk of progressing to GTN in patients with pre-
evacuation β HCG level ≥134.182,5mIU / ml 
was 77 times greater than in patients with pre-
evacuation β HCG levels <134.182,5 mIU/ml 
(OR = 77.008, P value = 0.004). While age, parity 
and histopathology feature were signifi cantly 
associated with β HCG level (OR > 1, p-value 
<0.05).
DISCUSSION
Gestational trophoblast disease (GTD) is defi ned 
as a neoplastic process, derived from fetal chorion 
during pregnancy.11,12 This includes a spectrum 
of diseases such as molar pregnancy, persistent 
invasive mole, gestational choriocarcinoma and 
placental-site trophoblast tumor.13,14
Gestational Trophoblast Neoplasm (GTN) is a 
disease condition where there is clinical evidence 
of invasive mole or choriocarcinoma. The 
incidence of gestational trophoblast neoplasm in 
Indonesia varies between 11.47 - 29.3%.3 In this 
study, we obtained 45 patients of hydatidiform 
moles; 15 (33.3%) of which developed into GTN. 
The number is relatively higher when compared 
to the incidence of post-mole GTN in Indonesia 
in previous studies, which range from 11.47 to 
29.3% .3 This may be due to Dr. Mohammad 
Hoesin Hospital Palembang status as a tertiary 
health care facility and a regional referral hospital. 
Hence, many subspecialists cases that cannot be 
handled at a local hospital can be found in Dr. 
Mohammad Hoesin Hospital.
Mean age of GTN patients in this study was 
35.13 ± 10.01 (age range 17-50), with statistical 
analysis showed signifi cant difference between 
mean age of the non-GNT patient and mean age 
of patients where mean age in GTN patients was 
higher. The results of this study are similar to 
the study by Azis et al who found an increasing 
incidence of invasive mole and choriocarcinoma 
in patients over 35-40 years old.15,16
Bivariate analysis showed that hydatidiform 
mole patients age ≥ 29.5 years old were 5.5 
times more at risk of progressing to GTN than 
patients age<29.5 years old. This result is not 
much different from Soeharyono's research in 
which patients age ≥ 35 years were 6.6 times 
more at risk of trophoblastic disease. However, 
a study conducted by Curry did not show a 
signifi cant relationship between age andpost-
mole malignancy.13-15
Table2. Association between Age, Parity, pre-evacuation β HCG Level, Histopathology Feature and Gestational Trophoblast 
Neoplasm Occurrence in Hydatidiform Mole Patients
Table3. Risk Factors of Gestational Trophoblast Neoplasm
**Regression logistic test,p-value=0.05
Characteristics
Variable
β HCG level
Histopathology 
feature
Parity
Age
196.000
56.000
5.500
5.500
0.000
0.000
0.024
0.025
77.008
7.423
5.025
0.813
0.004
0.227
0.295
0.890
Hydatidiform Mole
Unadjusted* Adjusted**
P-valueTotal OR*(CI 95%)GTN
OR OR
Non-GTN
P- value P- value
Age (years old)
≥ 29.5
< 29.5
Parity
≥ 1.5
< 1.5
Pre-evacuation β HCG level
≥ 134.182,5mIU/ml
< 134.182,5mIU/ml
Histopathology Feature
Moderate-severe
proliferation
Mild Proliferation
* Fisher Exact test, p-value = 0.05
11
4
10
5
14
1
14
1
6
24
20
25
10
20
8
22
2
28
21
24
18
27
16
29
5.500
(1.393-21.715)
0.025
0.024
0.000
0.000
5.500
( 1.434-21.096)
196.000
(16.337-2351.532)
56.000
(6.099-514.189)
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Majority of patients in this study, both in 
groups of GTN and non-GTN, have blood type 
B, followed by blood type A and blood type O. 
However, no AB blood type was found in both 
groups. With statistical analysis, there was no 
difference of blood type groups between the 
two groups. A research by Soeharyono (1996) 
showed that most malignancy cases occurred in 
blood type O patients, then blood type B, blood 
type A, and blood type AB. This difference is 
probably due to the smaller number of samples 
in this study compared to Soeharyono's study 
(321 samples), so the possibility of fi nding blood 
type O is higher. 13,16In the study by Aziz et al, 
patients with blood type O and B were found 
to be more likely to develop malignancy than 
patients with other blood types.13 While in the 
research conducted by Martaadisubrata in 2005, 
it was found that 33.3% of blood type A patients 
developed into choriocarcinoma.1 The results of 
Bagshawe's study found that blood type A had a 
higher risk for choriocarcinoma when the blood 
type of the husband was O.17
The association between parity (gravidity) 
and post-mole malignancy is still unclear. Some 
studies have found that the risk of malignancy 
was higher in higher parity, while other authors 
did not fi nd a relationship between parity and the 
risk of post-mole malignancy. 13,16 In this study, we 
found that hydatidiform mole patients with parity 
≥ 1.5 were 5.5 times more at risk of progressing 
to GTN than patients with parity<1.5. Statistical 
analysis showed a signifi cant association.
Curry found that patients with larger uterine 
size and an enlarged ovary have higher risk of 
post-mole malignancy. However, in this study, no 
difference in uterine size was found between the 
two groups. All GTN patients had larger uterine 
size than gestational age, and only one non-GTN 
patient had a uterine size in accordance with 
gestational age.15,16,18
The serum concentration of β HCG is 
recognised as an important prognostic indicator 
of gestational trophoblastic disease. According to 
FIGO, postevacuation treatment of hydatidiform 
mole involves examining β-HCG every week during 
the fi rst month until undetectable. The β-HCG 
level in most cases will return to normal within 
eight weeks, and the others will return to normal 
within 14-16 weeks after evacuation. Meanwhile, 
according to Berkowitz and Goldstein, β-HCG 
levels in hydatidiform mole patients usually 
will return to normal within 9-11 weeks after 
evacuation. However, if, during the follow-up, 
there is an elevated β-HCG level or plateau then 
the diagnosis of GTN can be established.13,19,20
In this study, the mean pre-evacuation β HCG 
level was 515286,4 ± 346728,0 mIu/ml. Then 
the preevacuation β HCG level was divided into 
≥134.182,5mIU/ml and <134.182,5 mIU/ml based 
on analysis results with ROC curve. With bivariate 
analysis, we found that hydatidiform mole patients 
with preevacuation β HCG level ≥134.182.5 mIU/
ml were signifi cantly more at risk (196 times more 
at risk)of progressing to GTN than patients with 
pre-evacuation β HCG level <134.182,5 mIU/ml. 
This result is similar to the study by Goldstein 
and Berkowitz which concluded that high pre-
evacuation β HCGtiter above 100,000 SI / l was a 
high-risk factor for malignancy. 14,15,17
In this study, we found that hydatidiform mole 
patients with moderate-to-severe proliferation 
from histopathology feature were signifi cantly 
more at risk (56 times higher) of progressing to 
GTN than patients with mild proliferation. This 
result is consistent with the study by Hertig and 
Sheldon, which found an association between 
the severity of trophoblastic hyperplasia in 
hydatidiform mole and the onset of malignancy. 
The more severe the hyperplasia and anaplasia 
found in histopathologic examinations, the 
more likely it is to become malignant. Based 
on the severity of hyperplasia and trophoblast 
cell anaplasia, a histologic hydatidiform mole 
classifi cation was formulated in 1956 and was 
simplifi ed by Hertig and Mansel.17
Based on multivariate analysis, the risk factor 
for the occurrence of gestational trophoblast 
neoplasm was preevacuation β HCG level ≥ 
134.182,5 mIU/ml while other variables were not 
risked factors because no statistically signifi cant 
correlation was found. The results were slightly 
different from the studies by Lurain JR and Loh 
KY et al. They reported that the risk factors 
for post hydatidiform mole malignancy were 
histopathologic features with severe proliferation, 
uterine size, lutein cysts> 6 cm and pre-evacuation 
β-HCG levels> 100,000 mIU / mL.8- 10
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CONCLUSIONS
Pre-evacuation β HCG levels ≥ 134,182.5 mIU/ml 
is a risk factor for the occurrence of GTN.
SUGGESTION
Follow-up studies with prospective cohort designs 
and large sample, which incorporate other risk 
factors should be conducted to provide more 
valid and targeted results and conclusions.
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